Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer|Solid Tumor|Thromboembolism|Cardiovascular Diseases|Immune System Diseases|Inflammatory Diseases|Colon Cancer|Breast Cancer|Prostate Cancer|Hepatocellular Carcinoma|Lung Cancer|Chemotherapy|Immunotherapy
Interventions: DRUG: Palbociclib|DRUG: Rivaroxaban|GENETIC: SNP
Sponsor: Lebanese University
Collaborators: Haykel Hospital